Piramal Pharma Ltd
NSE:PPLPHARMA
Wall Street
Price Targets
PPLPHARMA Price Targets Summary
Piramal Pharma Ltd
According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 296.37 INR with a low forecast of 227.25 INR and a high forecast of 357 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PPLPHARMA's stock price target?
Price Target
296.37
INR
According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 296.37 INR with a low forecast of 227.25 INR and a high forecast of 357 INR.
What is Piramal Pharma Ltd's Revenue forecast?
Projected CAGR
13%
For the last 2 years the compound annual growth rate for Piramal Pharma Ltd's revenue is 62%. The projected CAGR for the next 4 years is 13%.
What is Piramal Pharma Ltd's Operating Income forecast?
Projected CAGR
3%
For the last 2 years the compound annual growth rate for Piramal Pharma Ltd's operating income is 24%. The projected CAGR for the next 4 years is 3%.
What is Piramal Pharma Ltd's Net Income forecast?
Projected CAGR
179%
For the last 2 years the compound annual growth rate for Piramal Pharma Ltd's net income is -77%. The projected CAGR for the next 4 years is 179%.
You don't have any saved screeners yet
